A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.

NCT00503113 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

801

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-Menopausal Osteoporosis

Interventions

DRUG: ibandronate [Bonviva/Boniva]
DRUG: ibandronate [Bonviva/Boniva]
DRUG: Alendronate

Sponsor

Hoffmann-La Roche